Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method

Pilar Herrero, Carmen S. Dence, Terry L. Sharp, Michael J. Welch, Robert J. Gropler

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

In this study we demonstrated that significant egress of FDG from myocardium occurs within the first hour after tracer injection leading to nonlinear Patlak plots. There are also significant amounts of acidic FDG metabolites present in the blood. However, the impact of these metabolites on the estimates of myocardial glucose utilization (MGU) is negligible. Although further studies will be required to elucidate the reason for the egress of tracer from myocardium, not accounting for it will result in erroneous estimates of MGU.

Original languageEnglish
Pages (from-to)883-892
Number of pages10
JournalNuclear Medicine and Biology
Volume31
Issue number7
DOIs
StatePublished - Oct 1 2004

Keywords

  • FDG
  • Metabolism
  • Myocardium
  • Tomography

Fingerprint Dive into the research topics of 'Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and <sup>18</sup>F-fluorodeoxyglucose using the Patlak method'. Together they form a unique fingerprint.

Cite this